Literature DB >> 19290006

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.

Angela B Y Hui1, Wei Shi, Paul C Boutros, Naomi Miller, Melania Pintilie, Tony Fyles, David McCready, Derek Wong, Kate Gerster, Levi Waldron, Igor Jurisica, Linda Z Penn, Fei-Fei Liu.   

Abstract

Global micro-RNA (miR) profiling of human malignancies is increasingly performed, but to date, the majority of such analyses have used frozen tissues. However, formalin fixation is the standard and routine histological practice for optimal preservation of cellular morphology. To determine whether miR analysis of formalin-fixed tissues is feasible, quantitative real-time PCR (qRT-PCR) profiling of miR expression in 40 archival formalin-fixed paraffin-embedded (FFPE) breast lumpectomy specimens were performed. Taqman Low Density Arrays (TLDAs) were used to assess the expression level of 365 miRs in 34 invasive ductal carcinomas and in 6 normal comparators derived from reduction mammoplasties. Its technical reproducibility was high, with intra-sample correlations above 0.9 and with 92.8% accuracy in differential expression comparisons, indicating such global profiling studies to be technically and biologically robust. The TLDA data were confirmed using conventional single-well qRT-PCR analysis, showing a strong and statistically significant concordance between these two methods. Paired frozen and FFPE breast cancer samples from the same patients showed a similar level of robust correlation of at least 0.94. Compared with normal breast samples, a panel of miRs was consistently dysregulated in breast cancer, including earlier-reported breast cancer-related miRs, such as upregulated miR-21, miR-155, miR-191, and miR-196a, and downregulated miR-125b and miR-221. Additional novel miR sequences of potential biological relevance were also uncovered. These results show the validity and utility of conducting global miR profiling using FFPE samples, thereby offering enormous opportunities to evaluate archival banks of such materials, linked to clinical databases, to rapidly acquire greater insight into the clinically relevant role for miRs in human malignancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19290006     DOI: 10.1038/labinvest.2009.12

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  114 in total

1.  Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.

Authors:  Yu Miyazaki; Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Yue-Mei Jiang; Zhe Huang; Hideki Doi; Shinjiro Matsumoto; Naohide Kondo; Madoka Iida; Genki Tohnai; Fumiaki Tanaka; Shin-ichi Muramatsu; Gen Sobue
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data.

Authors:  Daryl Waggott; Kenneth Chu; Shaoming Yin; Bradly G Wouters; Fei-Fei Liu; Paul C Boutros
Journal:  Bioinformatics       Date:  2012-04-17       Impact factor: 6.937

Review 3.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

4.  High stability of microRNAs in tissue samples of compromised quality.

Authors:  Lorena Peiró-Chova; María Peña-Chilet; José Antonio López-Guerrero; José Luis García-Giménez; Elisa Alonso-Yuste; Octavio Burgues; Ana Lluch; Jaime Ferrer-Lozano; Gloria Ribas
Journal:  Virchows Arch       Date:  2013-10-03       Impact factor: 4.064

5.  Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA.

Authors:  Z Xu; D Nayak; W Yang; G Baskaran; S Ramachandran; N Sarma; A Aloush; E Trulock; R Hachem; G A Patterson; T Mohanakumar
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

6.  High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.

Authors:  Naohide Oue; Katsuhiro Anami; Aaron J Schetter; Markus Moehler; Hirokazu Okayama; Mohammed A Khan; Elise D Bowman; Annett Mueller; Arno Schad; Manabu Shimomura; Takao Hinoi; Kazuhiko Aoyagi; Hiroki Sasaki; Masazumi Okajima; Hideki Ohdan; Peter R Galle; Wataru Yasui; Curtis C Harris
Journal:  Int J Cancer       Date:  2013-11-08       Impact factor: 7.396

Review 7.  MicroRNA expression profiling in archival tissue specimens: methods and data processing.

Authors:  Thomas Streichert; Benjamin Otto; Ulrich Lehmann
Journal:  Mol Biotechnol       Date:  2012-02       Impact factor: 2.695

8.  Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens.

Authors:  Maja Kodani; Genyan Yang; Laura M Conklin; Tatiana C Travis; Cynthia G Whitney; Larry J Anderson; Stephanie J Schrag; Thomas H Taylor; Bernard W Beall; Robert F Breiman; Daniel R Feikin; M Kariuki Njenga; Leonard W Mayer; M Steven Oberste; Maria Lucia C Tondella; Jonas M Winchell; Stephen L Lindstrom; Dean D Erdman; Barry S Fields
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

9.  MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.

Authors:  Guang Yang; Dayong Han; Xin Chen; Daming Zhang; Lu Wang; Chen Shi; Weiguang Zhang; Chenguang Li; Xiaofeng Chen; Huailei Liu; Dongzhi Zhang; Jianhao Kang; Fei Peng; Ziyi Liu; Jiping Qi; Xin Gao; Jing Ai; Changbin Shi; Shiguang Zhao
Journal:  Neuro Oncol       Date:  2014-01-23       Impact factor: 12.300

10.  miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.

Authors:  Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; John Newell; Christophe Lemetre; Graham Balls; Michael J Kerin
Journal:  Int J Colorectal Dis       Date:  2012-08-18       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.